Genetic variants of the PITX3 gene are not associated with late-onset sporadic Parkinson's disease in a Chinese population

Neuroscience Letters

Volumn 498, Issue 2, 2011, Pages 124-126

  Cai, Yanning ^a   Ding, Hui ^a   Gu, Zhuqin ^a   Ma, Jinghong ^a   Chan, Piu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Case control study; Parkinson's disease; PITX3; Single nucleotide polymorphism

Indexed keywords

DNA FRAGMENT; TRANSCRIPTION FACTOR PITX3;

AGED; ARTICLE; ASSAY; CASE CONTROL STUDY; CHINESE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIGASE DETECTION REACTION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC PARKINSON DISEASE;

AGE OF ONSET; AGED; ALLELES; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; LIGASE CHAIN REACTION; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 79958736754     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.073     Document Type: Article

References (16)

1. Barzilai A., Melamed E. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease. Trends Mol. Med. 2003, 9:126-132.
2. Bergman O., Hakansson A., Westberg L., Nordenstrom K., Carmine A., Sydow O., Olson L., Holmberg B., Eriksson E., Nissbrandt H. PITX3 polymorphism is associated with early onset Parkinson's disease. Neurobiol. Aging 2010, 31:114-117.
3. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndrome of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 1973, 20:415-455.
4. Fuchs J., Mueller J.C., Lichtner P., Schulte C., Munz M., Berg D., Wullner U., Illig T., Sharma M., Gasser T. The transcription factor PITX3 is associated with sporadic Parkinson's disease. Neurobiol. Aging 2009, 30:730-738.
5. Golbe L.I. Young-onset Parkinson's disease: a clinical review. Neurology 1991, 41:168-173.
6. Gordon D., Finch S.J., Nothnagel M., Ott J. Power and sample size calculations for case-control genetic association tests when errors present: application to single nucleotide polymorphisms. Hum. Hered. 2002, 54:22-33.
7. Haubenberger D., Reinthaler E., Mueller J.C., Pirker W., Katzenschlager R., Froehlich R., Bruecke T., Daniel G., Auff E., Zimprich A. Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease. Neurobiol. Aging 2011, 32:302-307.
8. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
9. Hwang D.Y., Fleming S.M., Ardayfio P., Moran-Gates T., Kim H., Tarazi F.I., Chesselet M.F., Kim K.S. 3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J. Neurosci. 2005, 25:2132-2137.
10. Le W.D., Nguyen D., Lin X.W., Rawal P., Huang M., Ding Y.J., Xie W.J., Deng H., Jankovic J. Transcription factor PITX3 gene in Parkinson's disease. Neurobiol. Aging 2009, 10.1016/j.neurobiolaging.2009.03.015.
11. Luo Y., Tang S., Gao W., Chen L., Yang X., Huang T., Gao Y. Genotyping mitochondrial DNA single nucleotide polymorphisms by PCR ligase detection reactions. Clin. Chem. Lab. Med. 2010, 48:475-483.
12. McCulloch C.C., Kay D.M., Factor S.A., Samii A., Nutt J.G., Higgins D.S., Griffith A., Roberts J.W., Leis B.C., Montimurro J.S., Zabetian C.P., Payami H. Exploring gene-environment interactions in Parkinson's disease. Hum. Gene 2008, 123:257-265.
13. Messmer K., Remington M.P., Skidmore F., Fishman P.S. Induction of tyrosine hydroxylase expression by the transcription factor Pitx3. Int. J. Dev. Neurosci. 2007, 25:29-37.
14. Papapetropoulos S., Adi N., Ellul J., Argyriou A.A., Chroni E. A prospective study of familial versus sporadic Parkinson's disease. Neurodegener. Dis. 2007, 4:424-427.
15. Smidt M.P., Smits S.M., Burbach J.P. Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra. Cell Tissue Res. 2004, 318:35-43.
16. Yu L.H., Lin Z.F., Liu Y., Hu F.Y., He X.H., Liu Z.L., Xu Y.M. The transcription factor Pitx3 is a risk modifier for Parkinson's disease in a Chinese Han population. Eur. J. Neurol. 2011, 18:778-783.